Hamdi Nsairat
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems 11
- Advancements in Transdermal Drug Delivery 5
- Drug Solubulity and Delivery Systems 4
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 28
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications 5
- Molecular Biology top 10%
- Advanced biosensing and bioanalysis techniques 12
- RNA Interference and Gene Delivery 10
- Lipid Membrane Structure and Behavior 4
- Drug Discovery top 10%
- Co-authors
- Walhan AlshaerFadwa OdehAbeer Al BawabDima KhaterUsamah SayedEzaldeen EsawiSaid I. IsmailMohammad A. Ismail
- Partner nations
- JordanUnited Arab EmiratesUnited Kingdom
In The Last Decade
Hamdi Nsairat
53 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Pharmaceutical Science 401
- Biomaterials 668
- Molecular Medicine 154
- Molecular Biology 1.0k
- Drug Discovery 2
Countries citing papers authored by Hamdi Nsairat
This map shows the geographic impact of Hamdi Nsairat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamdi Nsairat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamdi Nsairat more than expected).
Fields of papers citing papers by Hamdi Nsairat
This network shows the impact of papers produced by Hamdi Nsairat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamdi Nsairat. The network helps show where Hamdi Nsairat may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hamdi Nsairat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 3 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 5 | |
| 8 | 2025 | 0 | |
| 9 | 2024 | 3 | |
| 10 | 2024 | 22 | |
| 11 | 2024 | 4 | |
| 12 | 2023 | 31 | |
| 13 | 2023 | 17 | |
| 14 | 2023 | 10 | |
| 15 | 2023 | 53 | |
| 16 | 2023 | 23 | |
| 17 | 2023 | 19 | |
| 18 | 2022 | 54 | |
| 19 | 2021 | 50 | |
| 20 | 2019 | 56 |
About Hamdi Nsairat
Hamdi Nsairat is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 62 papers that have together received 2.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (28 papers), Advanced biosensing and bioanalysis techniques (12 papers), Advanced Drug Delivery Systems (11 papers), RNA Interference and Gene Delivery (10 papers), Advancements in Transdermal Drug Delivery (5 papers), Curcumin's Biomedical Applications (5 papers), Drug Solubulity and Delivery Systems (4 papers) and Lipid Membrane Structure and Behavior (4 papers). The work is most often cited by research in Pharmaceutical Science (401 citations), Biomaterials (668 citations) and Molecular Medicine (154 citations). Hamdi Nsairat has collaborated with scholars based in Jordan, United Arab Emirates and United Kingdom. Frequent co-authors include Walhan Alshaer, Fadwa Odeh, Abeer Al Bawab, Dima Khater, Usamah Sayed, Ezaldeen Esawi, Said I. Ismail, Mohammad A. Ismail, Mohamed El‐Tanani and Abdalla Awidi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.